HK1045369A1 - Epitopes formed by non-covalent association of conjugates - Google Patents

Epitopes formed by non-covalent association of conjugates

Info

Publication number
HK1045369A1
HK1045369A1 HK02106716A HK02106716A HK1045369A1 HK 1045369 A1 HK1045369 A1 HK 1045369A1 HK 02106716 A HK02106716 A HK 02106716A HK 02106716 A HK02106716 A HK 02106716A HK 1045369 A1 HK1045369 A1 HK 1045369A1
Authority
HK
Hong Kong
Prior art keywords
conjugates
covalent association
ligand
epitopes formed
interacting
Prior art date
Application number
HK02106716A
Other languages
English (en)
Inventor
Roger New
Istvan Toth
Original Assignee
Mozaic Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mozaic Discovery Ltd filed Critical Mozaic Discovery Ltd
Publication of HK1045369A1 publication Critical patent/HK1045369A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432Liposomes or microcapsules
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/525Tumor necrosis factor [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Silicon Polymers (AREA)
HK02106716A 1999-06-28 2002-09-13 Epitopes formed by non-covalent association of conjugates HK1045369A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9915074.0A GB9915074D0 (en) 1999-06-28 1999-06-28 Ligand-binding composition
PCT/GB2000/002465 WO2001001140A1 (en) 1999-06-28 2000-06-27 Epitopes formed by non-covalent association of conjugates

Publications (1)

Publication Number Publication Date
HK1045369A1 true HK1045369A1 (en) 2002-11-22

Family

ID=10856190

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106716A HK1045369A1 (en) 1999-06-28 2002-09-13 Epitopes formed by non-covalent association of conjugates

Country Status (18)

Country Link
US (2) US7413538B1 (xx)
EP (2) EP1190255B1 (xx)
JP (1) JP4754136B2 (xx)
KR (1) KR100917285B1 (xx)
CN (1) CN100354628C (xx)
AT (2) ATE371190T1 (xx)
AU (1) AU775310B2 (xx)
BR (1) BR0012002A (xx)
CA (1) CA2377783C (xx)
DE (2) DE60036106T2 (xx)
DK (1) DK1190255T3 (xx)
ES (1) ES2292446T3 (xx)
GB (1) GB9915074D0 (xx)
HK (1) HK1045369A1 (xx)
IL (2) IL147249A0 (xx)
PT (1) PT1190255E (xx)
RU (1) RU2259194C2 (xx)
WO (1) WO2001001140A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504364B2 (en) 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
WO2005003326A2 (en) * 2003-03-28 2005-01-13 Receptors Llc. Artificial receptors including reversibly immobilized building blocks and methods
US7469076B2 (en) 2003-09-03 2008-12-23 Receptors Llc Sensors employing combinatorial artificial receptors
WO2006029234A1 (en) 2004-09-03 2006-03-16 Receptors Llc Combinatorial artificial receptors including tether building blocks
WO2006029383A2 (en) 2004-09-11 2006-03-16 Receptors Llc Combinatorial artificial receptors including peptide building blocks
SI2081952T1 (sl) * 2006-09-20 2014-05-30 Lexcicon Limited Peptidi
KR100840619B1 (ko) * 2006-12-19 2008-06-24 한양대학교 산학협력단 표면개질된 리포좀, 이를 포함하는 바이오칩 및 그제조방법
US9345753B2 (en) * 2008-01-16 2016-05-24 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Vaccine for alzheimer's disease
US20120157419A1 (en) 2009-02-02 2012-06-21 Tuvia Gilat Methods and compositions for treating alzheimer's disease
RU2500813C1 (ru) * 2012-10-15 2013-12-10 Федеральное казенное учреждение здравоохранения Ставропольский научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Способ получения липосомально-иммунопероксидазного конъюгата
KR101491728B1 (ko) * 2012-12-14 2015-02-11 주식회사 휴메딕스 비타민 c와 비타민 b3의 컨쥬게이트 및 그를 포함하는 항산화제

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US6024964A (en) 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3813821A1 (de) * 1988-04-22 1989-11-02 Hoechst Ag Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung
US6074650A (en) 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
ES2096064T3 (es) * 1991-12-19 1997-03-01 Ciba Geigy Ag Derivados del acido aminosulfonico y procedimiento para su obtencion.
WO1993022343A1 (en) 1992-05-01 1993-11-11 The Rockfeller University Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
JP2579730B2 (ja) * 1993-01-22 1997-02-12 株式会社ディ・ディ・エス研究所 ペプチド−脂質誘導体及びリポソーム
JPH09503645A (ja) * 1993-07-16 1997-04-15 ザ・ボード・オブ・トラスティーズ・オブ・ザ・リランド・スタンフォード・ジュニアー・ユニバーシティ 制御されたアポトーシス
JP3759759B2 (ja) * 1994-03-04 2006-03-29 日本油脂株式会社 リポソームおよび薬物運搬体
ATE208633T1 (de) * 1994-09-16 2001-11-15 Merck Patent Gmbh Immunokonjugate
US6214388B1 (en) * 1994-11-09 2001-04-10 The Regents Of The University Of California Immunoliposomes that optimize internalization into target cells
US5741899A (en) * 1995-02-02 1998-04-21 Cell Genesys, Inc. Chimeric receptors comprising janus kinase for regulating cellular pro liferation
US5851536A (en) * 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
DK0912195T3 (da) * 1996-06-25 2009-05-18 Pepscan Systems Bv Vaccine indeholdende antigener bundet til bærestoffer gennem labile bindinger
JPH10234372A (ja) * 1997-02-27 1998-09-08 Boehringer Mannheim Corp キメラ受容体を有する細胞とその作成方法、並びに その利用
US6217886B1 (en) * 1997-07-14 2001-04-17 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved micelle compositions
FR2774687B1 (fr) * 1998-02-06 2002-03-22 Inst Nat Sante Rech Med Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
CA2327367A1 (en) * 1998-04-07 1999-10-14 Roche Diagnostics Gmbh New compounds for dna-transfection
FR2776926B1 (fr) * 1998-04-07 2003-10-24 Inst Nat Sante Rech Med Lipopeptides inducteurs de cytotoxicite t lymphocytaire portant au moins un epitope t auxiliaire, et leurs utilisations pour la vaccination
AU3191100A (en) * 1999-03-17 2000-10-04 Mitsubishi Chemical Corporation Ligand-bonded complex
AU3673500A (en) * 1999-04-08 2000-11-14 Mitsubishi Chemical Corporation Fine particles targeting cells and process for producing the same
AU766570B2 (en) * 1999-04-23 2003-10-16 Mitsubishi Chemical Corporation Antibody and polyalkylene glycol-bonded liposome
AU769425B2 (en) * 1999-04-23 2004-01-29 Alza Corporation Conjugate having a cleavable linkage for use in a liposome

Also Published As

Publication number Publication date
EP1722227A2 (en) 2006-11-15
PT1190255E (pt) 2007-09-18
US20080152703A1 (en) 2008-06-26
KR100917285B1 (ko) 2009-09-11
EP1190255A1 (en) 2002-03-27
AU5692300A (en) 2001-01-31
CN1359469A (zh) 2002-07-17
ATE457460T1 (de) 2010-02-15
IL147249A (en) 2007-08-19
ATE371190T1 (de) 2007-09-15
GB9915074D0 (en) 1999-08-25
US7413538B1 (en) 2008-08-19
DE60036106T2 (de) 2008-05-15
BR0012002A (pt) 2002-03-12
CA2377783C (en) 2010-03-23
EP1190255B1 (en) 2007-08-22
JP2003503424A (ja) 2003-01-28
ES2292446T3 (es) 2008-03-16
RU2259194C2 (ru) 2005-08-27
EP1722227A3 (en) 2007-02-28
KR20020042537A (ko) 2002-06-05
AU775310B2 (en) 2004-07-29
EP1722227B1 (en) 2010-02-10
DE60043830D1 (de) 2010-03-25
WO2001001140A1 (en) 2001-01-04
DE60036106D1 (de) 2007-10-04
JP4754136B2 (ja) 2011-08-24
CN100354628C (zh) 2007-12-12
IL147249A0 (en) 2002-08-14
CA2377783A1 (en) 2001-01-04
DK1190255T3 (da) 2007-12-10

Similar Documents

Publication Publication Date Title
HK1045369A1 (en) Epitopes formed by non-covalent association of conjugates
ES1049907U (es) Peonzas de juguete.
SG165158A1 (en) Calicheamicin derivative-carrier conjugates
IL132669A0 (en) Multivalent vaccine composition with mixed carrier
ATE144523T1 (de) Glykosylierte arzneimittel-vorstufen, verfahren zu ihrer herstellung und ihre verwendungen
WO2002096367A3 (en) Targeted multivalent macromolecules
NO171542C (no) Passasjersete, saerlig beregnet paa barn
ITMI941154A1 (it) Macchina per formare pacchi di fogli fascettati
DE69013015T2 (de) Protein aus dem Cytosol, das FK-506 binden kann.
IT8921837A0 (it) Composizione di combustibile ad elevato contenuto energetico, contenete quadriciclano.
ES541497A0 (es) Un mecanismo de ajuste de fuerza descendente para aperos agricolas tales como sembradoras,arados y similares.
EP1247658A3 (en) Binder
DE69003526D1 (de) Hochgeschwindigkeits-Einwickelmaschine für empfindliche Produkte mit komplizierter Form, welche noch in der Aushärtungsphase sind.
GB2385519B (en) Folding linkage
JP2001165877A5 (xx)
JPS54108076A (en) Feeder for 3-dimensional transfer feeders
SU474415A1 (ru) Устройство дл образовани флюсовой подушки
JPS51146024A (en) Slide means for reclining seat
ES2186457A1 (es) Sistema mecanico de desplazamiento de elementos moviles perfeccionado.
ES1055801U (es) Alineador de envases sin presion.
ES2101812T3 (es) Maquina circular multi alimentada para tejer punto.
JPS5435921A (en) Travelling speed change operating mechanism of movable agricultural machine
JPS5588343A (en) Wire bonder
IT1250879B (it) Gruppo ottico per veicoli.
TH7572EX (th) เบาะเลี้ยงเด็ก

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110627